Trials / Withdrawn
WithdrawnNCT01492569
Acupuncture Point Stimulation for Treatment of Chemotherapy Nausea and Vomiting
- Status
- Withdrawn
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- Stanford University · Academic / Other
- Sex
- All
- Age
- 8 Years – 21 Years
- Healthy volunteers
- Not accepted
Summary
This randomized pilot clinical trial studies giving acupuncture in reducing nausea and vomiting in patients undergoing chemotherapy. Pressing and stimulating nerves at an acupuncture point on the inside of the wrist may help control nausea and vomiting during chemotherapy.
Detailed description
PRIMARY OBJECTIVE: I. To determine whether transcutaneous acupuncture point stimulation (TAPS) at P6 as an adjuvant treatment to standard antiemetic therapy reduces acute chemotherapy induced nausea and vomiting as compared to sham acupuncture point stimulation in children undergoing their first round of highly or moderately emetogenic chemotherapy. OUTLINE: Patients are randomized to 1 of 2 treatment arms. ARM I: Patients undergo TAPS at the true acupuncture point (P6) 30 minutes prior to first chemotherapy infusion and then four times a day for 20 minutes every 2 hours at 8am, 10am, 12pm, and 2pm. Patients then crossover to Arm II for the second course of chemotherapy. ARM II: Patients undergo TAPS at a sham non-acupuncture point 30 minutes prior to first chemotherapy infusion and then four times a day for 20 minutes every 2 hours at 8am, 10am, 12pm, and 2pm. Patients then crossover to Arm I for the second course of chemotherapy.
Conditions
- Childhood Acute Lymphoblastic Leukemia
- Childhood Acute Myeloid Leukemia/Other Myeloid Malignancies
- Ewing Sarcoma
- Vomiting in Infants and/or Children
- Osteosarcoma
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | electroacupuncture therapy | Undergo TAPS at sham point |
| OTHER | questionnaire administration | Ancillary studies |
| PROCEDURE | electroacupuncture therapy | Undergo TAPS |
Timeline
- Start date
- 2012-05-01
- Primary completion
- 2013-07-01
- First posted
- 2011-12-15
- Last updated
- 2013-06-12
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01492569. Inclusion in this directory is not an endorsement.